TQH3906 placebo

DRUG3 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Inflammatory Bowel DiseasesPsoriasisSystemic Lupus Erythematosus

Phase 1

A Clinical Trial of TQH3906 Capsules in Healthy Volunteers

CompletedNCT06230588

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Psoriasis

Start: 2024-02-02End: 2025-04-27Updated: 2025-07-16

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

RecruitingNCT06754891

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Inflammatory Bowel Diseases

Start: 2025-01-28End: 2027-12-01Target: 135Updated: 2026-05-12

Phase 2

A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

RecruitingNCT07509892

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Systemic Lupus Erythematosus

Start: 2026-06-22End: 2028-03-01Target: 198Updated: 2026-07-08